The study purpose was to examine perspectives of women with newly diagnosed breast cancer-related lymphedema (BCRL) regarding their quality of life over seven years.
Method
Data were collected over seven years using the Lymphedema and Breast Cancer Questionnaire (LBCQ). Participants with BCRL answered open-ended questions corresponding to changes in mood and lifestyle from post-op through annual interviews and surveys. Self-reported data from 97 participants with BCRL were analyzed using in vivo coding and template-style content analysis to elicit the impact of BCRL on quality of life domains.
Results
Data saturation was achieved as participants neared 30 to 36 months post- breast cancer diagnosis. Three major themes were identified related to BCRL’s impact on: physical function; daily living and social function; and psychological function.
Discussion
Findings suggest that BCRL impacts quality of life not only soon after diagnosis, but also throughout survivorship years. Healthcare providers should develop programs to enhance quality of life for survivors with BCRL.
LawendaBDMondryTEJohnstoneP.Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin2009;
59: 8–24.
2.
ShaitelmanSFCromwellKDRasmussenJC, et al.
Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin2015;
65: 55–81.
3.
Executive Committee.The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology. Lymphology2016;
49: 170–184.
4.
PusicALCemalYAlbornozC, et al.
Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv2013;
7: 83–92.
5.
TaghianNRMillerCLJammalloLS, et al.
Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol2014;
92: 227–234.
6.
BeaulacSMMcNairLAScottTE, et al.
Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg2002;
137: 1253–1257.
7.
DeanLTMossSLRansomeY, et al.
It still affects our economic situation: long-term economic burden of breast cancer and lymphedema. Support Care Cancer2019;
27: 1967–1708.
PaskettEDStarkN.Lymphedema: knowledge, treatment, and impact among breast cancer survivors. Breast J2000;
6: 373–378.
10.
RocksonSG.Lymphatic medicine: paradoxically and unnecessarily ignored. Lymph Res Biol2017;
15: 315–316.
11.
DiSipioTRyeSNewmanB, et al.
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol2013;
14: 500–515.
12.
McLaughlinSADeSnyderSMKlimbergS, et al.
Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema, recommendations from an expert panel: part 2: preventive and therapeutic options. Ann Surg Oncol2017;
24: 2827–2835.
13.
American Cancer Society. Breast cancer facts & figures 2017-2018.
Atlanta:
American Cancery Society, 2017.
14.
ArmerJMRadinaEPorockD, et al.
Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res2003;
52: 370–379.
15.
ArmerJMFeldmanJLOstbyPL, et al.
Simplifying evidence-based management of breast cancer-related lymphedema. Exp Rev Qual Life Cancer Care2016;
1: 389–402.
16.
FöldiEFöldiMRocksonSG. Complete decongestive physiotherapy. In: Lee B-B, Rockson SG and Bergan J (eds) Lymphedema: a concise compendium of theory and practice 2015. Cham: Springer International Publishing, pp. 403–411.
17.
LasinskiBBThriftKMSquireD, et al.
A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R2012;
4: 580–601.
18.
BurckhardtMBelznerMBergA, et al.
Living with breast cancer-related lymphedema: a synthesis of qualitative research. Oncol Nurs Forum2014;
41: E220–E237.
19.
GillespieTCSayeghHEBrunelleCL, et al.
Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg2018;
7: 379–403.
20.
FuMRRidnerSHHuSH, et al.
Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psycho-Oncology2013;
22: 1466–1484.
21.
MareeJEBeckmannD.Just live with it: having to live with breast cancer related lymphedema. Health SA Gesondheid2016;
21: 77–85.
22.
MeiklejohnJAHeeschKCJandaM, et al.
How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia. Support Care Cancer2013;
21: 459–466.
23.
ViehoffPBGielinkPDCDamstraRJ, et al.
Functioning in lymphedema from the patients’ perspective using the International Classification of Functioning, Disability and health (ICF) as a reference. Acta Oncol2015;
54: 411–421.
24.
CornelissenAJMKoolMKeuterXHA, et al.
Quality of life questionnaires in breast cancer-related lymphedema patients: review of the literature. Lymph Res Biol2018;
16: 134–139.
25.
HormesJMBryanCLytleLA, et al.
Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology2010;
43: 1–13.
26.
BakasTMcLennonSMCarpenterJS, et al.
Systematic review of health-related quality of life models. Health Qual Life Outcomes2012;
10: 134.
27.
KarimiMBrazierJ.Health, health-related quality of life, and quality of life: what is the difference?Pharmacoeconomics2016;
34: 645–649.
28.
Bojinovic-RodicDPopovic-PetrovicSTomicS, et al.
Upper extremity function and quality of life in patients with breast cancer related lymphedema. Vojnosanit Pregl2016;
73: 825–830.
29.
FarquharM.Definitions of quality of life: a taxonomy. J Adv Nurs1995;
22: 502–508.
30.
Ferrans CE. Definitions and conceptual models of quality of life. In: JLipscombCCGotayCSnyder (eds) Outcomes assessment in cancer: measures, methods, and applications.
Cambridge, UK:
Cambridge University Press, 2006, pp.14–30.
ArmerJMStewartBR.A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymph Res Biol2005;
3: 208–217.
35.
ArmerJMStewartBR.Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphol2010;
43: 118–127.
36.
VaismoradiMTurunenHBondasT.Content analysis and thematic analysis: implications for conducting a qualitative descriptive study: qualitative descriptive study. Nurs Health Sci2013;
15: 398–405.
37.
GraneheimUHLundmanB.Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today2004;
24: 105–112.
HsiehH-F.Three approaches to qualitative content analysis. Qual Health Res2005;
15: 1277–1288.
40.
MilesMBHubermanAMSaldañaJ.Qualitative data analysis: a methods sourcebook. 4th ed.
Los Angeles:
SAGE, 2020.
41.
SaldañaJ.The coding manual for qualitative researchers.
Los Angeles:
SAGE, 2013.
42.
Thomas-MacLeanRMiedemaBTatemichiSR.Breast cancer-related lymphedema: women's experiences with an underestimated condition. Can Fam Physician2005;
51: 246–247.
43.
WanchaiAStewartBRArmerJM.Experiences and management of breast cancer-related lymphoedema: a comparison between South Africa and the United States of America. Int Nurs Rev2012;
59: 117–124.
44.
FuMRRosedaleM.Breast cancer survivors’ experiences of lymphedema-related symptoms. J Pain Symptom Manage2009;
38: 849–859.
45.
DominickSANatarajanLPierceJP, et al.
The psychosocial impact of lymphedema-related distress among breast cancer survivors in the WHEL Study: the psychosocial impact of breast cancer-related lymphedema. Psychooncology2014;
23: 1049–1056.
46.
Chance-HetzlerJArmerJVan LooM, et al.
Prospective lymphedema surveillance in a clinic setting. J Pers Med2015;
5: 311–325.
47.
HayesSCJohanssonKStoutNL, et al.
Upper-body morbidity after breast cancer. Cancer2012;
118: 2237–2249.
48.
WanchaiAArmerJMStewartBR, et al.
Breast cancer-related lymphedema: a literature review for clinical practice. Int J Nurs Sci2016;
3: 202–207.
49.
McDuffSGRMinaAIBrunelleCL, et al.
Timing of lymphedema following treatment for breast cancer: when are patients most at-risk?Intl J Radiat Oncol Biol Phys2019;
103: 62–70.
